Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Chesnara, Itaconix, IXICO, MP Evans, Quadrise - Small Cap Week in Review

Chesnara, Itaconix, IXICO, MP Evans, Quadrise - Small Cap Week in Review

Chesnara PLC (LSE:CSN) CEO Steve Murray says two major acquisitions have transformed the group's scale, with around £1 billion in expected lifetime cash flows. He's relaxed about market volatility and says the balance sheet could support another deal similar in size to Scottish Widows Europe. Watch more

Itaconix PLC (AIM:ITX, OTCQB:ITXXF, FRA:18G0) CEO John Shaw says revenues hit $10.5 million last year, up 61%, and he's targeting $25 to $30 million within five years. The plant-based ingredient company is winning business across detergent brands in both Europe and North America. Watch more

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden says its new Medidata partnership opens the door to thousands of global clinical trials. The collaboration strengthens IXICO’s ability to scale, giving the company access to larger and more complex clinical trials. Watch more

MP Evans Group PLC (AIM:MPE) had a record 2025 — gross profit hit $142 million on the back of strong palm oil prices and bigger harvests. The company is debt-free, still buying land, and says 2026 has started well. Watch more

Quadrise PLC (AIM:QED) CEO Peter Borup says the company is down to two outstanding items before its large-scale trial with MSC and Cargill can move forward. While the green transition remains important, cost competitiveness is critical in the current environment. Watch more

Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.